• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多次新型冠状病毒病 2019 分子检测:严重急性呼吸综合征冠状病毒 2 培养与分子检测和循环阈值的相关性。

Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds.

机构信息

Department of Pathology, Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

National Institutes of Allergy and Infectious Disease, Bethesda, Maryland, USA.

出版信息

Clin Infect Dis. 2021 Aug 16;73(4):e860-e869. doi: 10.1093/cid/ciaa1616.

DOI:10.1093/cid/ciaa1616
PMID:33104776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7665437/
Abstract

BACKGROUND

Repeated coronavirus disease 2019 (COVID-19) molecular testing can lead to positive test results after negative results and to multiple positive results over time. The association between positive test results and infectious virus is important to quantify.

METHODS

A 2-month cohort of retrospective data and consecutively collected specimens from patients with COVID-19 or patients under investigation were used to understand the correlation between prolonged viral RNA positive test results, cycle threshold (Ct) values and growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cell culture. Whole-genome sequencing was used to confirm virus genotype in patients with prolonged viral RNA detection. Droplet digital polymerase chain reaction was used to assess the rate of false-negative COVID-19 diagnostic test results.

RESULTS

In 2 months, 29 686 specimens were tested and 2194 patients underwent repeated testing. Virus recovery in cell culture was noted in specimens with a mean Ct value of 18.8 (3.4) for SARS-CoV-2 target genes. Prolonged viral RNA shedding was associated with positive virus growth in culture in specimens collected up to 21 days after the first positive result but mostly in individuals symptomatic at the time of sample collection. Whole-genome sequencing provided evidence the same virus was carried over time. Positive test results following negative results had Ct values >29.5 and were not associated with virus culture. Droplet digital polymerase chain reaction results were positive in 5.6% of negative specimens collected from patients with confirmed or clinically suspected COVID-19.

CONCLUSIONS

Low Ct values in SARS-CoV-2 diagnostic tests were associated with virus growth in cell culture. Symptomatic patients with prolonged viral RNA shedding can also be infectious.

摘要

背景

反复进行 2019 年冠状病毒病(COVID-19)分子检测可能会导致阴性结果后出现阳性检测结果,并随着时间的推移出现多次阳性结果。阳性检测结果与传染性病毒之间的关联对于定量很重要。

方法

使用为期 2 个月的回顾性队列数据和连续收集的 COVID-19 患者或疑似患者的标本,了解延长的病毒 RNA 阳性检测结果、循环阈值(Ct)值与 SARS-CoV-2 在细胞培养中生长之间的相关性。对延长病毒 RNA 检测的患者进行全基因组测序以确认病毒基因型。使用液滴数字聚合酶链反应评估 COVID-19 诊断检测结果假阴性的发生率。

结果

在 2 个月内,共检测了 29686 份标本,有 2194 名患者进行了重复检测。在平均 Ct 值为 18.8(3.4)的 SARS-CoV-2 靶基因标本中观察到病毒在细胞培养中的恢复。在首次阳性结果后长达 21 天采集的标本中,延长的病毒 RNA 脱落与培养中阳性病毒生长相关,但主要发生在标本采集时出现症状的个体中。全基因组测序提供了证据表明同一病毒随时间推移而传播。在首次阴性结果后出现的阳性检测结果 Ct 值>29.5,与病毒培养无关。从确诊或临床疑似 COVID-19 患者采集的 5.6%的阴性标本中,液滴数字聚合酶链反应结果为阳性。

结论

SARS-CoV-2 诊断检测中的低 Ct 值与细胞培养中的病毒生长相关。延长的病毒 RNA 脱落的有症状患者也可能具有传染性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/bfb05b37b70d/ciaa1616f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/9a5eb30f940d/ciaa1616f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/4fb4cef03de6/ciaa1616f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/d0cedeb10248/ciaa1616f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/df050e86cd13/ciaa1616f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/74252ec2e19c/ciaa1616f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/ffc6b9dc8d7c/ciaa1616f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/bfb05b37b70d/ciaa1616f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/9a5eb30f940d/ciaa1616f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/4fb4cef03de6/ciaa1616f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/d0cedeb10248/ciaa1616f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/df050e86cd13/ciaa1616f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/74252ec2e19c/ciaa1616f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/ffc6b9dc8d7c/ciaa1616f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ff/8366819/bfb05b37b70d/ciaa1616f0007.jpg

相似文献

1
Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds.多次新型冠状病毒病 2019 分子检测:严重急性呼吸综合征冠状病毒 2 培养与分子检测和循环阈值的相关性。
Clin Infect Dis. 2021 Aug 16;73(4):e860-e869. doi: 10.1093/cid/ciaa1616.
2
Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.新型冠状病毒肺炎成年住院患者痰液与鼻咽拭子标本中 2019 年冠状病毒脱落持续时间的差异。
Chest. 2020 Nov;158(5):1876-1884. doi: 10.1016/j.chest.2020.06.015. Epub 2020 Jun 20.
3
Duration of infectious virus shedding in patients with severe coronavirus disease 2019 who required mechanical ventilation.需要机械通气的 2019 年冠状病毒病重症患者的传染性病毒排出时间。
J Infect Chemother. 2022 Jan;28(1):19-23. doi: 10.1016/j.jiac.2021.09.006. Epub 2021 Sep 10.
4
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.SARS-CoV-2 侧向流动抗原检测的比较性能及其与临床标本中传染性病毒检测的关联:一项单中心实验室评估研究。
Lancet Microbe. 2021 Sep;2(9):e461-e471. doi: 10.1016/S2666-5247(21)00143-9. Epub 2021 Jun 30.
5
Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19).复制型有传染性的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)在患有严重或危重症 2019 冠状病毒病(COVID-19)的患者中的排出持续时间。
Clin Infect Dis. 2023 Feb 8;76(3):e416-e425. doi: 10.1093/cid/ciac405.
6
Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)抗原检测结果、实时逆转录聚合酶链反应(rRT-PCR)循环阈值、亚基因组 RNA 和病毒培养结果相关的流行病学特征,来自大学检测。
Clin Infect Dis. 2021 Sep 15;73(6):e1348-e1355. doi: 10.1093/cid/ciab303.
7
Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.韩国无症状和轻症 COVID-19 患者粪便样本中 SARS-CoV-2 的检测。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1387-1394.e2. doi: 10.1016/j.cgh.2020.06.005. Epub 2020 Jun 10.
8
Viral Haplotypes in COVID-19 Patients Associated With Prolonged Viral Shedding.新冠病毒患者中与病毒持续排出相关的病毒单倍型。
Front Cell Infect Microbiol. 2021 Nov 3;11:715143. doi: 10.3389/fcimb.2021.715143. eCollection 2021.
9
Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa.南非免疫功能低下的人类免疫缺陷病毒(HIV)感染者住院患者中高病毒载量下严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的长时间脱落。
Clin Infect Dis. 2022 Aug 24;75(1):e144-e156. doi: 10.1093/cid/ciac077.
10
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.SARS-CoV-2 RNA 存在于 COVID-19 患者的粪便中。
J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.

引用本文的文献

1
COVID-19 infection and pulmonary sarcoidosis: a systematic review and meta-analysis of morbidity, severity and mortality.新型冠状病毒肺炎感染与肺结节病:发病率、严重程度及死亡率的系统评价与荟萃分析
J Thorac Dis. 2025 Feb 28;17(2):744-752. doi: 10.21037/jtd-24-1620. Epub 2025 Feb 27.
2
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.一种替代酶联免疫吸附测定法,用于筛选高滴度人恢复期血浆,以治疗感染严重急性呼吸综合征冠状病毒2变异株的免疫功能低下患者。
J Infect Dis. 2025 Apr 15;231(4):e723-e733. doi: 10.1093/infdis/jiae645.
3

本文引用的文献

1
Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.最初阴性患者中随后出现的严重急性呼吸综合征冠状病毒 2 逆转录聚合酶链反应阳性的发生和时间。
Clin Infect Dis. 2021 Jan 27;72(2):323-326. doi: 10.1093/cid/ciaa722.
2
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test.多中心评估 NeuMoDx™ SARS-CoV-2 测试。
J Clin Virol. 2020 Sep;130:104583. doi: 10.1016/j.jcv.2020.104583. Epub 2020 Aug 7.
3
Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays.
Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates.
从 PCR 数据预测传染性病毒的存在:非人类灵长类动物中 SARS-CoV-2 的荟萃分析。
PLoS Pathog. 2024 Apr 29;20(4):e1012171. doi: 10.1371/journal.ppat.1012171. eCollection 2024 Apr.
4
Increased circulation of human adenovirus in 2023: an investigation of the circulating genotypes, upper respiratory viral loads, and hospital admissions in a large academic medical center.2023 年人类腺病毒循环增加:在大型学术医疗中心调查循环基因型、上呼吸道病毒载量和住院情况。
J Clin Microbiol. 2024 Jan 17;62(1):e0123723. doi: 10.1128/jcm.01237-23. Epub 2023 Dec 19.
5
Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study.轻度原发性和复发性 COVID-19 医护人员传染性丧失的时间和预测因素:一项前瞻性观察队列研究。
Clin Infect Dis. 2024 Mar 20;78(3):613-624. doi: 10.1093/cid/ciad535.
6
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit.Fluorecare新型冠状病毒刺突蛋白检测试剂盒的真实世界评估。
Adv Lab Med. 2021 May 24;2(3):409-416. doi: 10.1515/almed-2021-0041. eCollection 2021 Aug.
7
SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022.乌干达献血者中 2019-2022 年 SARS-CoV-2 血清流行率。
Transfusion. 2023 Jul;63(7):1354-1365. doi: 10.1111/trf.17449. Epub 2023 Jun 16.
8
COVID-19 Antigen Results Correlate with the Quantity of Replication-Competent SARS-CoV-2 in a Cross-Sectional Study of Ambulatory Adults during the Delta Wave.在一项针对三角洲波期间门诊成年人的横断面研究中,COVID-19 抗原检测结果与具有复制能力的 SARS-CoV-2 数量相关。
Microbiol Spectr. 2023 Jun 15;11(3):e0006423. doi: 10.1128/spectrum.00064-23. Epub 2023 Apr 25.
9
Respiratory Adenovirus Quantification with a Droplet Digital Polymerase Chain Reaction (ddPCR) Assay.采用液滴式数字聚合酶链反应(ddPCR)检测法定量呼吸道腺病毒。
Microbiol Spectr. 2023 Jun 15;11(3):e0026923. doi: 10.1128/spectrum.00269-23. Epub 2023 Apr 18.
10
Comparison of Real-time RT-PCR cycle threshold (Ct) values with clinical features and severity of COVID-19 disease among hospitalized patients in the first and second waves of COVID-19 pandemic in Chennai, India.印度钦奈第一波和第二波新冠疫情大流行期间住院患者实时逆转录聚合酶链反应(RT-PCR)循环阈值(Ct)值与新冠疾病临床特征及严重程度的比较
J Clin Virol Plus. 2023 Jun;3(2):100146. doi: 10.1016/j.jcvp.2023.100146. Epub 2023 Mar 28.
七种常用的商业 SARS-CoV-2 自动化分子检测方法的分析灵敏度比较。
J Clin Virol. 2020 Sep;130:104578. doi: 10.1016/j.jcv.2020.104578. Epub 2020 Aug 5.
4
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.SARS-CoV-2 病毒培养及轻症冠状病毒病患者呼吸道标本的亚基因组 RNA
Emerg Infect Dis. 2020 Nov;26(11):2701-2704. doi: 10.3201/eid2611.203219. Epub 2020 Aug 4.
5
Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection.用于 SARS-CoV-2 检测的液滴数字 PCR 灵敏度评估。
Int J Mol Med. 2020 Sep;46(3):957-964. doi: 10.3892/ijmm.2020.4673. Epub 2020 Jul 13.
6
Comparison of Unsupervised Home Self-collected Midnasal Swabs With Clinician-Collected Nasopharyngeal Swabs for Detection of SARS-CoV-2 Infection.居家自采中鼻甲拭子与临床医生采集鼻咽拭子用于检测 SARS-CoV-2 感染的比较。
JAMA Netw Open. 2020 Jul 1;3(7):e2016382. doi: 10.1001/jamanetworkopen.2020.16382.
7
Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results.生物样本采集不充分可能是导致 COVID-19 诊断检测结果假阴性的原因。
J Infect Dis. 2020 Aug 17;222(6):899-902. doi: 10.1093/infdis/jiaa370.
8
Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.鼻咽拭子和唾液检测严重急性呼吸综合征冠状病毒 2 的敏感性。
Clin Infect Dis. 2021 Mar 15;72(6):1064-1066. doi: 10.1093/cid/ciaa848.
9
Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).用于检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的口咽后部唾液
Clin Infect Dis. 2020 Dec 31;71(11):2939-2946. doi: 10.1093/cid/ciaa797.
10
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19.美国传染病学会关于新冠病毒病诊断的指南
Clin Infect Dis. 2020 Jun 16. doi: 10.1093/cid/ciaa760.